According to a new report Europe Coronary stents Market, published by KBV research, the Europe Coronary stents Market would witness market growth of 7.3% CAGR during the forecast period (2018 – 2024).
The Micro porous Surface market would dominate the Europe Coronary Stents Market by Polymer Free Drug Eluting Stents Type by 2024. The Nanoporous Surface market is expected to witness a CAGR of 8.5% during (2018 - 2024). The Micro Structured Surface market is expected to witness a CAGR of 6.4% during (2018 - 2024).
The Germany market dominated the Europe Bioresorbable Vascular Scaffold Market by Country in 2017. The UK market is expected to witness a CAGR of 8.8% during (2018 - 2024). Additionally, The France market is expected to witness a CAGR of 9.8% during (2018 - 2024).
The Drug-eluting stents (DES) market dominated the France Coronary Stents Market by Product Type in 2017, and would achieve a market value of $312.8 million by 2024. The Bare-Metal Stents market is expected to witness a CAGR of 7.4% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/europe-coronary-stents-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT, Terumo Medical Corporation, Medtronic Plc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical Incorporated, Johnson & Johnson, Biotronik SE & Co. KG, Biosensors International Group Ltd.
By Product Type
By Country
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
North America Coronary Stents Market
Unique Offerings 
